PHAT
Phathom Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -4.4% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | +3 | 31.41M | $340.87M | +8 | −5 |
| Q1 2026 | 70 | +3 | 28.31M | $314.61M | +9 | −6 |
| Q4 2025 | 67 | +2 | 22.91M | $380.11M | +2 | — |
| Q3 2025 | 13 | +2 | 15.27M | $179.73M | +2 | — |
| Q2 2025 | 8 | -4 | 10.36M | $99.34M | — | −4 |
| Q1 2025 | 9 | 0 | 3.37M | $21.12M | — | — |
| Q4 2024 | 9 | 0 | 2.95M | $23.99M | +2 | −2 |
| Q3 2024 | 8 | +2 | 2.05M | $37.04M | +3 | −1 |
| Q2 2024 | 6 | — | 1.55M | $15.95M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 1.04M | — | $8.44M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 1.02M | +18.0% | $8.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 1.02M | +18.0% | $8.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 485.79K | +215.4% | $3.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 136.00K | -21.6% | $1.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 136.00K | -21.6% | $1.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 98.07K | Nieuw | $796,312 | 0.0% | New | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 98.07K | Nieuw | $796,312 | 0.0% | New | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 98.07K | Nieuw | $796,312 | 0.0% | New | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 72.01K | -67.3% | $584,697 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 59.99K | +82.2% | $487,127 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 25.64K | +21.8% | $209,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 17.66K | Nieuw | $143,383 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 17.66K | Nieuw | $143,383 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $796,312 | 0.0% |
| Marshall Wace | $796,312 | 0.0% |
| Marshall Wace | $796,312 | 0.0% |
| AQR Capital Management | $143,383 | 0.0% |
| AQR Capital Management | $143,383 | 0.0% |
Verlaten
| Point72 Asset Management | $7.95M | was 0.0% |
| D. E. Shaw & Co. | $2.60M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 173 houders, 68.60M aandelen, $741.84M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.